Results 211 to 220 of about 61,613 (221)

Irinotecan

Reactions Weekly, 2018
openaire   +2 more sources

A Randomized Phase III Multicenter Trial Comparing Irinotecan in Combination With the Nordic Bolus 5-FU and Folinic Acid Schedule or the Bolus/Infused De Gramont Schedule (Lv5FU2) in Patients With Metastatic Colorectal Cancer

Annals of Oncology, 2008
Bengt Glimelius, P Byström, M Albertsson   +2 more
exaly  

A Phase I/II and Pharmacokinetic Study of Irinotecan in Combination With Capecitabine as First-Line Therapy for Advanced Colorectal Cancer

Annals of Oncology, 2005
W W Ten Bokkel Huinink, J W R Nortier, N Steven   +2 more
exaly  

A Randomized Multicenter Phase II Study Comparing Capecitabine With Irinotecan or Cisplatin in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Annals of Oncology, 2010
Peter R Galle, M Geissler, M P Ebert
exaly  

Irinotecan

Reactions Weekly, 1993
openaire   +1 more source

Irinotecan

Reactions Weekly
openaire   +2 more sources

Predictive Factors of Survival in Patients With Advanced Colorectal Cancer: An Individual Data Analysis of 602 Patients Included in Irinotecan Phase III Trials

Annals of Oncology, 2004
David Cunningham, J -Y Douillard, E Mitry   +2 more
exaly  

Phase II Study of Irinotecan and 5-Fluorouracil/Leucovorin in Patients With Primary Refractory or Relapsed Advanced Oesophageal and Gastric Carcinoma

Annals of Oncology, 2004
David Cunningham, Gina Brown, J S Waters
exaly  

A Phase II Multicentre Study of Irinotecan (CPT 11) in Combination With Cisplatin (CDDP) in Metastatic or Locally Advanced Penile Carcinoma (EORTC PROTOCOL 30992)

Annals of Oncology, 2008
S Marreaud, I Bodrogi, C Theodore
exaly  

A Phase III Randomised Trial of LV5FU2 + Irinotecan Versus LV5FU2 Alone in Adjuvant High-Risk Colon Cancer (FNCLCC Accord02/FFCD9802)

Annals of Oncology, 2009
Michel Ducreux, Andrew Kramar, J -Y Douillard   +2 more
exaly